What Biolight does

Guangdong Biolight Meditech Co., Ltd. (Biolight, ticker 300246 on the Shenzhen Stock Exchange) is a Chinese medical device company founded in 1993 and listed since 2011. It designs, manufactures, and sells patient monitoring systems, blood purification equipment (hemodialysis machines, dialyzers, and consumables), infusion pumps, ECG and life-science products, home healthcare devices, and veterinary instruments. Its technology portfolio includes PPG-based respiratory rate monitoring, the first such implementation in China, and the D800Plus three-pump hemodiafiltration system. The company holds 41 invention patents, 246 utility model patents, and design patents, alongside ISO9001, ISO13485, ISO14001, CE, FDA 510(k), CMD, and CCC certifications, and was recognized as a National Manufacturing Single-Champion Enterprise in 2024.

Biolight operates seven industrial bases across China (Guangdong, Jiangsu, Jiangxi, Hubei, Liaoning, Chongqing, and Tianjin) plus a German R&D and manufacturing operation established in 2017. Manufacturing capacity includes a 60,000 sqm Blood Purification Industrial Base completed in 2022 with a 500M CNY investment, supporting vertical integration from dialyzer production through dialysis machine assembly. The product line spans mid-range to high-acuity monitors (P Series, ICU solutions launched 2025), the BioFusion infusion platform, and the Remote View System for centralized monitoring, indicating a portfolio depth targeting both general ward and high-acuity clinical settings.

The business model is B2B medical device sales to hospitals, clinics, and distributors, with quotation-based institutional pricing and aftermarket revenue from consumables (dialyzers, blood lines, sensors) and service contracts. The company serves 5,000+ hospitals in China via a 21-province service network and exports to 150+ countries, holding the #1 shipment position in India's patient monitor market for eight consecutive years. Growth is driven by a mix of capital equipment refresh cycles, recurring consumable demand from the dialysis installed base, and geographic expansion into Latin America, the Middle East, and North America.

Name

Biolight

Legal name

Guangdong Biolight Meditech Co., Ltd.

Website

https://blt.com.cn

Company type

Public

Founded year

1993

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Guangdong Biolight Meditech Co., Ltd. (Biolight) is a Shenzhen-listed Chinese medical device company that designs, manufactures, and sells patient monitoring systems, blood purification equipment, infusion devices, and home healthcare products to hospitals and clinics across 150+ countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

IV Therapy, Infusion & Fluid Management (Pumps, Catheters, Fluid Sets) (HLAMAFAG), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Anesthesia, Ventilation & Patient Monitoring (Machines, Vaporizers, Monitors) (HLAMAFAB), Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests) (CRADAMAK)

Keywords

• Patient monitoring systems
• Hemodialysis equipment
• Blood purification devices
• Infusion pump systems
• Medical device manufacturing

Headquarters

HQ city

Zhuhai

HQ country

China

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of patient monitors, blood purification equipment, home healthcare devices and related consumables. Products include multi-parameter monitors, hemodialysis machines, dialyzers, infusion pumps, and home care products. Revenue generated through direct sales, distributors, and service networks.
2. After-sales Service and Support: Technical support, product training, maintenance services, and customer support through service centers across China and globally

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Biolight designs, manufactures, and sells medical devices across three main categories: (1) Life Information and Support — multi-parameter patient monitors, modular ICU monitors, transport monitors, ECG machines, fetal monitors, and infusion/syringe pumps; (2) Nephrology/Blood Purification — hemodialysis machines, hollow fiber dialyzers, peritoneal dialysis equipment, dialysis powder, fluid filters, fistula needles, and reverse osmosis water equipment; and (3) Home Healthcare — fingertip pulse oximeters, wrist blood pressure monitors, and handheld patient monitors. The company also offers veterinary variants of its monitors and pumps, alongside after-sales service and an IoT-based equipment management platform.

Product overview

Biolight (广东宝莱特医用科技股份有限公司) is a comprehensive medical device company offering a multi-product portfolio organized into four main categories: Life Information and Support (patient monitors, infusion pumps, ECG machines, fetal monitors), Nephrology/Blood Purification (hemodialysis machines, dialyzers, peritoneal dialysis equipment), Home Healthcare (pulse oximeters, blood pressure monitors), and Veterinary Care (veterinary monitors and pumps). The product line spans from high-end modular patient monitors (P series, Q series, M series) to transport monitors (P1), infusion systems (Biofusion pumps, DS100 workstation), blood purification equipment (D800Plus, D800H, D800S hemodialysis machines), and home-use devices. The portfolio includes both core hospital-grade equipment and portable/handheld devices for various clinical settings including ICU, OR, general ward, emergency, and home care.

Differentiator

Problem solved

Functional benefit

Brands

• BIOVISION: Central monitoring system for patient monitoring inside and outside the hospital
• BioFusion
• Remote View
• Biofluid

Products and services

• Multi-parameter Patient Monitors (P, Q, M, G, S, V series) Multi-parameter patient monitor family covering P series high-end modular monitors (P12, P15, P18, P22), Q series modular monitors (Q3, Q5, Q7), M series monitors (M10, M12), G series semi-modular monitors (G10, G12, G15), S series compact monitors (S10, S12), V series vital signs monitors (V6, V9), and the P1 transport monitor — for ICU, OR, general ward, and emergency department use.
• Central Monitoring System (M6000C, BIOVISION) Central monitoring system for hospital-wide multi-patient surveillance at nursing stations, with real-time data aggregation from bedside monitors.
• Biofusion Infusion and Syringe Pumps (P300, P500, S300, S500, DS100) Biofusion family of infusion and syringe pumps — including TCI-equipped P300 syringe pump, P500 large volume pump, S300 syringe pump, S500 large volume pump, and DS100 infusion work station — for precise drug and fluid delivery in clinical settings.
• ECG Machines (E30, E65, E70, E80) Digital ECG machines spanning E30 entry-level, E65 and E70 standard 12-lead, and E80 digital models for diagnostic cardiac assessment in clinics and hospitals.
• Fetal Monitors (F30, F50, F80, F90) Fetal monitor family including F30 basic heart rate, F50 and F80 standard obstetric, and F90 antepartum/intrapartum models for maternal and fetal vital sign tracking.
• Fingertip Pulse Oximeters (M70, M70A, M70B, M70C) Family of fingertip pulse oximeters for SpO2 and pulse rate measurement in clinical and home settings, including variants for clinical accuracy, self-monitoring, and spot-check use.
• Wrist Blood Pressure Monitors (WBP202, WBP302) Wrist blood pressure monitors for home use with standard and advanced measurement features.
• Handheld Patient Monitors (M800, M850, M860, M880) Family of handheld portable patient monitors (M800 through M880) for portable vital sign monitoring across care settings.
• Hemodialysis Machines (D800S, D800H, D800Plus) D800 series of hemodialysis machines including D800S for standard blood purification, D800H for renal replacement therapy, and D800Plus — China's first three-pump hemodiafiltration device with high-sensitivity touchscreen, IC card information retrieval, six professional curves, and IoT monitoring of blood pressure, oxygen, and volume parameters.
• PD600 Peritoneal Dialysis Equipment Automated peritoneal dialysis equipment for home-based renal replacement therapy.
• Hollow Fiber Dialyzer Hollow fiber membrane dialyzer for blood filtration during hemodialysis, CE certified for European market.
• Blood Purification Consumables (Fluid Filter DF210, Dialysis Powder, Citric Acid Disinfectant, Fistula Needle, RO Water Equipment) Recurring-use hemodialysis consumables including DF210 fluid filter (PES membrane, 2.1 m² effective area, endotoxin ≤0.03 EU/mL), dialysis powder, citric acid disinfectant for machine decalcification, CE-certified fistula needles in 15G/16G/17G, and RO water purification equipment.
• C100 Video Laryngoscope Video laryngoscope for airway management and intubation in clinical and emergency settings.
• UM100 Urine Monitor Urine monitor for continuous output measurement in critical care, part of the Biofluid comprehensive fluid management solution.
• Veterinary Monitors and Pumps (G series Vet, P12 Vet, S12 Vet, M12 Vet, M800-M880 Vet, M500 Vet, M300 Vet, S500 Vet, S300 Vet, E30 Vet) Veterinary variants of Biolight's monitor, syringe pump, large volume pump, and ECG product lines adapted for animal care in veterinary clinics and animal hospitals.
• After-sales Service and Technical Support Technical support, product training, maintenance services, and customer support delivered through service centers across 21 provinces and autonomous regions in China and through global distribution partners.

Quantifiable outcome

• D800Plus achieves higher toxin clearance than pre-dilution hemodiafiltration with safer profile than post-dilution
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Four partnerships are on record, tiered moderate, minor and core.

• China International Engineering Consulting Corporation (中咨公司)moderateStrategic or Co-development Partner · 9 March 2023Strategic exchange and consultation visit to Biolight headquarters. CICEC is a central enterprise under State-owned Assets Supervision and Administration Commission, China's largest comprehensive engineering consulting institution. Visit focused on discussing medical equipment industry development, blood purification technology R&D achievements, and industrial chain planning.
• Turkish Red Crescent (土耳其红新月会)minorOthers · 21 February 2023Donation of fingertip pulse oximeters for earthquake relief following Turkey-Syria earthquake disaster. Relief supplies delivered through Biolight's local Turkish employees.
• German Operations BasecoreStrategic or Co-development Partner · 1 January 2017Established R&D and manufacturing operations in Germany in 2017 to adopt European advanced management experience and technology in blood purification to promote localization of hemodialysis equipment and consumables.
• Tianjin Trust-ever Medical Equipment Development Co., Ltd.coreStrategic or Co-development Partner · 1 January 2012Acquisition in 2012 marked Biolight's entry into blood purification field. This acquisition enabled expansion into hemodialysis equipment and consumables market.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Asahi Kasei Medical: Japanese manufacturer of dialysis membranes (hollow fiber dialyzers) and therapeutic apheresis products. Directly comparable to Biolight's hollow fiber dialyzer offering and competes on CE-certified membranes in international markets.
• Edan Instruments: Guangdong-based peer competing head-to-head with Biolight in patient monitors, ECG machines, fetal monitors, and ultrasound. Very similar product portfolio in the China mid-tier hospital segment and selected international markets.
• Nihon Kohden: Japanese leading patient monitor and EEG manufacturer with strong Asia-Pacific presence. Competes with Biolight in mid-to-high-end modular patient monitors and central monitoring systems, particularly in Asian hospital tenders.
• Yuwell (Jiangsu Yuyue Medical Equipment): China-based medical device company with overlapping home healthcare (blood pressure monitors, pulse oximeters) and patient monitoring products. Competes with Biolight in both consumer-facing home devices and hospital-grade monitoring.
• Contec Medical Systems: China-based manufacturer of patient monitors, ECG, pulse oximeters, and home healthcare devices. Directly competes with Biolight in the home use and entry-level clinical monitoring categories, especially in export markets.
• Mindray: Shenzhen-based global medical device leader and the most direct competitor to Biolight in patient monitoring, in-vitro diagnostics, and medical imaging. Both are Chinese A-share MedTech companies with overlapping product lines in multi-parameter monitors, infusion pumps, and increasingly in blood purification.
• Nipro Corporation: Japanese medical device manufacturer with a major dialysis business (machines, dialyzers, blood lines, fistula needles). Directly comparable to Biolight across the full blood purification supply chain and competes in many of the same emerging markets.

Broad incumbents

• Drägerwerk: German medical and safety technology company with a strong patient monitoring and anesthesia portfolio. Offers overlapping ICU monitoring and central station capabilities to Biolight's P-series and BIOVISION system.
• Fresenius Medical Care: Global leader in dialysis products and services, operating the largest network of dialysis clinics. Competes with Biolight's blood purification business across hemodialysis machines, dialyzers, and consumables, especially in international markets.
• B. Braun Avitum: German-based division of B. Braun focused on hemodialysis machines, dialyzers, and water treatment systems. Competes with Biolight's D800-series hemodiafiltration platform and is a key rival for European and emerging-market renal tenders.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCO_DmPm1mndfOXleohXQ5BA
• Facebookm.facebook.com/BiolightBLT
• LinkedInlinkedin.com/company/guangdong-biolight-meditech-co-ltd-

Compliance10 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biolight